Non-Hodgkin’s Lymphoma

Non-Hodgkin’s lymphoma refers to a group of blood cancers that develop from white blood cells. Studies have shown an increased risk of developing non-Hodgkin’s lymphoma after exposure to the glyphosate weed killer sold under the brand name Roundup®¹. Roundup was manufactured and sold by Monsanto until 2018, when the brand name and the product line were acquired by Bayer.

Federal court juries determined that Monsanto was aware of the risks associated with exposure to Roundup and failed to notify the public.  These juries have awarded billions to those who developed non-Hodgkin’s after exposure to Roundup². If you have been diagnosed with non-Hodgkin’s lymphoma or Chronic Lymphocytic Leukemia and have been exposed to Roundup, you may be eligible to file a claim.

¹LuPong, Zhang; Rana, Iemaan; Schaeffer, Rachel M., Taioli; Emanuela & Sheppard, Lianee. Exposure to glyphosate-based herbicide and risk for non-Hodgkin’s lymphoma: A meta-analysis and supporting data. Elsevier Science Direct. Volume 781, July-September, 2019. pp. 186-206.

²Cohen, Patricia. $2 Billion Dollar Verdict Against Monsanto Is Third to Find Roundup Caused Cancer. The New York Times. May 13, 2019